Alpha Cognition (ACOG) EBT Margin (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly EBT Margin of 283.75% for Q4 2025, down 711.56% quarter-over-quarter from 46.4% in Q3 2025.

Alpha Cognition (ACOG) EBT Margin (2025 - 2026) Analysis & Trends

Alpha Cognition's EBT Margin history runs 1 years deep, the most recent figure standing at 283.75% for Q4 2025.

In Q4 2025, EBT Margin changed N/A year-over-year to 283.75%; the TTM figure through Dec 2025 stood at 213.43% (changed N/A YoY), while the FY2025 annual figure was 416.35%, changed N/A from the prior year.
EBT Margin for Q4 2025 stood at 283.75%, down from 46.4% in the prior quarter.
The five-year high for EBT Margin was 46.4% in Q3 2025, with the low at 796.24% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Vertex Pharmaceuticals	139.47 Bn	131.61 Bn	2.84 Bn	41.75%
2	Regeneron Pharmaceuticals	86.36 Bn	78.37 Bn	3.93 Bn	35.61%
3	Argenx Se	65.16 Bn	59.98 Bn	1.37 Bn	35.71%
4	Moderna	58.99 Bn	53.85 Bn	52.00 Mn	-528.97%
5	BeOne Medicines	42.08 Bn	36.98 Bn	1.53 Bn	18.33%
6	Alnylam Pharmaceuticals	31.74 Bn	28.43 Bn	992.69 Mn	13.77%
7	BioNTech SE	28.01 Bn	9.61 Bn	668.28 Mn	-25.06%
8	Insmed	27.50 Bn	26.34 Bn	358.27 Mn	-2.67%
9	Royalty Pharma	27.28 Bn	26.45 Bn	-	12.09%
10	Alpha Cognition	206.09 Mn	164.65 Mn	5.70 Mn	-121.05%

Download Data